Evidence map›Paper›PMID 40156869›Full record

ArticleNucleic acids research2025

PfGCN5 is essential for Plasmodium falciparum survival and transmission and regulates Pf H2B.Z acetylation and chromatin structure.

Jingyi Tang, Lee M Yeoh, Myriam D Grotz, Christopher D Goodman, Scott A Chisholm, Hanh H T Nguyen, Chunhao Yu, Kapil Pareek, Fairley McPherson, Anton Cozijnsen and 8 more

Erratum issuedAbstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Pediatric MixedChildren (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Jingyi TangSchool of Medicine, Deakin University, Waurn Ponds, Victoria 3216, Australia.
Lee M YeohDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria 3000, Australia.ORCID 0000-0001-7872-762X
Myriam D GrotzMikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, 91054 Erlangen, Germany.
Christopher D GoodmanSchool of BioSciences, The University of Melbourne, Parkville, Victoria 3052, Australia.
Scott A ChisholmSchool of BioSciences, The University of Melbourne, Parkville, Victoria 3052, Australia.
Hanh H T NguyenBio21 Institute, 30 Flemington Road Parkville, Victoria 3052, Australia.
Chunhao YuMikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, 91054 Erlangen, Germany.ORCID 0009-0008-3137-6736
Kapil PareekMikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, 91054 Erlangen, Germany.
Fairley McPhersonDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria 3000, Australia.
Anton CozijnsenSchool of BioSciences, The University of Melbourne, Parkville, Victoria 3052, Australia.
Samuel A HustadtMikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, 91054 Erlangen, Germany.
Gabrielle A JoslingDepartment of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria 3052, Australia.
Karen P DayDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria 3000, Australia.
Danae SchulzThe Department of Biology, Harvey Mudd College, Claremont, CA 91711, United States.
Geoffrey I McFaddenSchool of BioSciences, The University of Melbourne, Parkville, Victoria 3052, Australia.
Tania F de Koning-WardSchool of Medicine, Deakin University, Waurn Ponds, Victoria 3216, Australia.
Michaela PetterDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria 3000, Australia.ORCID 0000-0002-1837-2756
Michael F DuffyDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria 3000, Australia.ORCID 0000-0001-5635-4033

Funding

German Academic Exchange ServiceGerman Research Foundation 433302244Global Health Innovative Technology Fund T2016-203National Health and Medical Research Council GNT1128975National Science Foundation 2041395Next Generation Sequencing Competence Network 423957469Universities Australia
6 · The paper itself

Abstract

Plasmodium falciparum causes most malaria deaths. Its developmental transitions and environmental adaptation are partially regulated by epigenetic mechanisms. Plasmodium falciparum GCN5 (PfGCN5) is an epigenetic regulator that acetylates lysines and can also bind to acetylated lysine residues on histones via its bromodomain (BRD). Here, we showed that PfGCN5 was essential for parasite transmission and survival in human blood and mosquitoes. PfGCN5 regulated genes important for metabolism and development and its BRD was required at euchromatic gene promoters for their proper expression and for acetylation of the variant histone Pf H2B.Z. However, PfGCN5 was most abundant in heterochromatin and loss of the PfGCN5 BRD de-repressed heterochromatic genes and increased levels of acetylated Pf H2B.Z in heterochromatin. The PfGCN5 BRD-binding compound L-45 phenocopied deletion of the PfGCN5 BRD, identifying PfGCN5 as a promising drug target for BRD inhibitors. Thus, PfGCN5 appears to directly contribute to activating euchromatic promoters, but PfGCN5 is also critical for maintaining repressive heterochromatin structure.

Indexed as

ChromatinHistone AcetyltransferasesHistonesMalaria, FalciparumPlasmodium falciparumProtozoan ProteinsAcetylationAnimalsHeterochromatinHumansPromoter Regions, GeneticChromatinHeterochromatinHistone AcetyltransferasesHistonesProtozoan Proteins

Identifiers

PMID40156869
PMCPMC11954527

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.